NNN

NEUROTECH OPT JAN25

No trades
See on Supercharts

Key stats

Market capitalization
‪91.56 M‬AUD
Dividend yield (indicated)
Price to earnings Ratio (TTM)
Basic EPS (TTM)
Net income (FY)
Revenue (FY)
Shares float
Beta (1Y)
0.55

About NEUROTECH OPT JAN25

Headquarters
Nedlands
Founded
2016
ISIN
AU0000265837
FIGI
BBG01DQ1WPS8
Neurotech International Ltd. engages in the research, design, development, and manufacture of medical devices and solutions in Australia. Its product includes Mente Autism for the diagnosis and treatment of autism. The company was founded on January 15, 2016 and is headquartered in Nedlands, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.